Printer Friendly

CNS ENTERS INTO A LICENSE AGREEMENT WITH CREATIVE INTEGRATION AND DESIGN; ANNOUNCES NEW PRESIDENT

 CNS ENTERS INTO A LICENSE AGREEMENT WITH CREATIVE INTEGRATION
 AND DESIGN; ANNOUNCES NEW PRESIDENT
 MINNEAPOLIS, Feb. 5 /PRNewswire/ -- CNS, Inc. (NASDAQ: CNXS) today reported that it has entered into a license agreement dated Jan. 30, 1992, with Creative Integration and Design, Inc. (CID) pursuant to which CNS has acquired the exclusive right to manufacture and sell an external nasal dilator developed by CID. The dilator, tentatively referred to as BreatheRight(TM), is a disposable device that is intended to perform the same function as dilators presently being sold which must be placed inside the nostrils to reduce the work of nasal breathing.
 Daniel E. Cohen, M.D., chief executive officer, said that CNS intends to file a 510(k) submission with the FDA during March 1992 and, assuming the requisite FDA clearance is received, to begin selling the BreatheRight device in late 1992. Cohen also said that the BreatheRight device will be initially marketed to patients who require nasal oxygen administration.
 CNS also reported that its president, Fred Brooks, resigned to pursue other business interests effective Jan. 31, 1992. Brooks' duties will be assumed by Cohen.
 CNS designs, manufactures and markets computer-based systems for data compilation and analysis in the sleep laboratory and operating rooms.
 -0- 2/5/92
 /CONTACT: Daniel E. Cohen, CEO of CNS, 612-474-7600/
 (CNXS) CO: CNS, Inc. ST: Minnesota IN: CPR SU: LIC


AL -- MN003 -- 7042 02/05/92 09:14 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 5, 1992
Words:236
Previous Article:INTERACTIVE MEDIA TECHNOLOGIES ANNOUNCES THE IMTX 4000 TO BE RELEASED (Product Announcement)
Next Article:PROPERTY TRUST OF AMERICA ANNOUNCES DIVIDEND DECLARATION
Topics:


Related Articles
LAWSUIT FILED AGAINST CNS, INC.
AEQUITRON MEDICAL ACQUIRES ADULT SLEEP DIAGNOSTIC BUSINESS FROM CNS
CNS, INC., REACHES SETTLEMENT IN BREATHE RIGHT SUIT
CNS, INC., SAYS UNDERWRITERS EXERCISED OVER-ALLOTMENT OPTION
CNS, Inc., Reports on Patent Enforcement Actions
CNS, Inc., Chooses Healthdyne Technologies To Market Breathe Right Strip To Professional Medical Market
CNS, Inc., Selects Martin/Williams as Advertising Agency of Record
CNS, Inc., Announces Share Buy-Back Plan
CNS Chooses Campbell Mithun Esty As Marketing Communications Agency

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters